ABEO:NASDAQ
Abeona Therapeutics Inc
$5.62
arrow_upward
+0.63%(+0.035) 1D
Sep 18, 12:36:33 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ABEO...
Open
$5.82
High
$5.84
Low
$5.52
Mkt. cap
321.66M
Avg. vol.
1.63M
Volume
979.45K
52-wk high
$7.65
52-wk low
$4.00
EPS
-$1.12
Beta
1.33
Shares outstanding
57.18M
No. of employees
226
Open
$5.82
High
$5.84
Low
$5.52
Mkt. cap
321.66M
Avg. vol.
1.63M
Volume
979.45K
52-wk high
$7.65
52-wk low
$4.00
EPS
-$1.12
Beta
1.33
Shares outstanding
57.18M
No. of employees
226
News stories
From web sources and news partners
Benzinga
·
4 hours ago
Apple To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Friday
Investing.com
·
4 hours ago
Cantor raises Abeona stock price target on partner drug approval
Benzinga
·
4 hours ago
Abeona Stands to Collect Royalties After Ultragenyx's FDA Approval — Here's the Rest of the Week
Stock Titan
·
5 hours ago
A gene therapy for Sanfilippo syndrome gets U.S. approval. Abeona helped develop it.
About Abeona Therapeutics Inc
CEO-
Employees226
Founded1974
HeadquartersCleveland, Ohio, United States
SectorBiotechnology
Websiteabeonatherapeutics.com